Valneva SE (EPA:VLA)
4.776
+0.364 (8.25%)
Aug 15, 2025, 5:38 PM CET
Valneva SE Employees
Valneva SE had 713 employees as of December 31, 2024. The number of employees increased by 37 or 5.47% compared to the previous year.
Employees
713
Change (1Y)
37
Growth (1Y)
5.47%
Revenue / Employee
€280,467
Profits / Employee
€95,773
Market Cap
812.23M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
EssilorLuxottica Société anonyme | 153,498 |
Sanofi | 82,878 |
Sartorius Stedim Biotech | 9,901 |
bioMérieux | 14,754 |
Eurofins Scientific SE | 62,696 |
Ipsen | 5,358 |
ABIVAX Société Anonyme | 69 |
Virbac | 6,365 |
Valneva SE News
- 3 days ago - Valneva SE 2025 Q2 - Results - Earnings Call Presentation - Seeking Alpha
- 3 days ago - Valneva SE (VALN) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 4 days ago - Valneva reports 1H results; reaffirms FY outlook - Seeking Alpha
- 4 days ago - Valneva Reports Half Year 2025 Financial Results and Provides Corporate Updates - GlobeNewsWire
- 8 days ago - FDA lifts pause on Valneva's chikungunya vaccine in elderly - Seeking Alpha
- 9 days ago - Valneva Announces Removal of FDA-Recommended Pause on Use of Chikungunya Vaccine IXCHIQ® in Elderly and Updates to the Prescribing Information - GlobeNewsWire
- 17 days ago - AGC Biologics' Heidelberg Site Supplies Drug Substance for Phase II Studies of Valneva's Tetravalent Shigella Vaccine Candidate - Business Wire
- 5 weeks ago - Valneva Announces Lifting of European Medicines Agency's Temporary Restriction on Use of Chikungunya Vaccine IXCHIQ® in Elderly - GlobeNewsWire